New pill could help shed pounds: obesity drug trial begins
Disease control
Recruiting now
This study tests an experimental oral drug, ERX1000, for weight loss in 80 adults with obesity (BMI 30-50). Participants will take the drug or a placebo daily for 24 weeks. The main goals are to check safety and see how much weight is lost. This is an early-phase trial, so the dr…
Phase: PHASE2 • Sponsor: ERX Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC